Cullen/Frost Bankers’s Medline Inc MDLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.18M Buy
207,498
+18,895
+10% +$761K 0.08% 190
2026
Q1
$8.39M Buy
188,603
+188,105
+37,772% +$8.31M 0.1% 181
2025
Q4
$20.9K Buy
+498
New +$21K ﹤0.01% 993

Other funds holding MDLN

Cullen/Frost Bankers's MDLN Position: Q2 2026 in Review

Cullen/Frost Bankers increased its Medline Inc (MDLN) stake by 10% in Q2 2026, buying an estimated $761K and bringing the position to 207,498 shares worth $8.18M. The position accounts for 0.08% of the portfolio, ranked #190.

Cullen/Frost Bankers first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.39M in Q1 2026. 162 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Cullen/Frost Bankers held 207,498 shares of Medline Inc worth $8.18M as of Q2 2026.
  • Cullen/Frost Bankers bought 18,895 Medline Inc shares in Q2 2026, an estimated $761K.
  • Medline Inc made up 0.08% of Cullen/Frost Bankers's portfolio in Q2 2026, its #190 holding.
  • Cullen/Frost Bankers first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Cullen/Frost Bankers's Medline Inc position peaked at $8.39M in Q1 2026.
  • 162 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Cullen/Frost Bankers's 13F filing for Q2 2026, filed 27 Jul 2026.